Equity
€18,600 from €664,066 in 2022
Equity fell by 97% in 3 years.
DR. TOM BOGAERT
Lifetime
11 annual accounts with figures on one time axispeak €335,721 (2021)
€268,099▼ 17.4%
peak €249,254 (2021)
€197,485▼ 16.3%
peak €664,066 (2022)
€18,600▼ 96.4%
€518,050▲ 15×
peak 1 FTE (2017)
-not published
Board1 name since 2015
1 director
Documentsfilings and deeds
16-07-202615 days before the deadline
2025micro format
Gross margin from €324,687 to €268,099Dividend €693,143Equity from €514,258 to €18,600Debts from €34,784 to €518,050Cash from €253,557 to €100,607
Key points
from the 2025 annual accountsTurnover
≈ €410,000 estimated
The micro format states no turnover.
Debts
€518,050 97% of the balance sheet
Suppliers 2%Taxes and wages 3%Other 95%
Liquidity
1.01 was 34.87 in 2024
Short-term debts rose from €15,196 to €518,050.
Filings
11 annual accounts since 2015
Seven of the last ten came late. The 2022 accounts came latest: 30 days after the end of the period.
Position in the sector
3.5%
Lower solvency than 91% of companies in human health. Sector median 63.0% · 20,774 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 536 companies had the same profile as DR. TOM BOGAERT has now. Each dot stands for 2 companies, two years later.
95.9%
were still trading
3.4%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 536 companies, not a prediction for DR. TOM BOGAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0597967683
Resignation: (manager)
Reappointment: (director) · Gazette deed
Registered office moved within Bornem
New registered office: Reek 86, 2880 Bornem · Previous registered office: Reek 28, 2880 Bornem · General meeting of 28-09-2017 · Gazette deed
Registered office moved from Damme to Bornem
New registered office: Reek 28, 2880 Bornem · Previous registered office: Dorpsstraat 24 bus 7, 8340 Damme · General meeting of 01-10-2016 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. TOM BOGAERT Bornem | €536,650 | €268,099 | 3.5% | - |
| Dr. Nathalie van Meir Brasschaat | €539,577 | €268,636 | 74.6% | - |
| Dr. Heymans Julie Balen | €540,185 | €252,193 | 34.4% | - |
| Dr. Dominiek Despriet, oogarts Kalmthout | €585,447 | €282,774 | 35.3% | - |
| UROLOGIEPRAKTIJK FRANSIS Brasschaat | €615,647 | €254,277 | 5.5% | - |
| DEBLAERE ISABEL, ANESTHESIE Knokke-Heist | €536,401 | €273,808 | 24.0% | - |
| DR. SOFIE DEPUYDT, HEELKUNDE Ostend | €507,436 | €285,441 | 54.3% | - |
These companies have the same main activity as DR. : specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €507,000 and €616,000, founded between 2014 and 2015.
Official details
Source: KBO- Status
- Active since 13-02-2015Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.239.417.9172880 Bornem, since 13-02-2015
- Financial year end
- 31 December
- Peppol
- Reachable since 09-01-2026
Annual accounts 2025
- €536,650▼ 2.3%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on DR. TOM BOGAERT
DR. files the micro format. That format states no turnover. The gross margin rose from €245,154 in 2015 to €268,099 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. TOM BOGAERT
- What is the company number of DR. TOM BOGAERT?
- The company number of DR. is 0597.967.683. The VAT number is the same number with BE in front: BE 0597.967.683.
- Where is DR. TOM BOGAERT based?
- The registered office is at Reek 86, 2880 Bornem.Company details
- What does DR. TOM BOGAERT do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. TOM BOGAERT?
- DR. is a private limited company (BV).
- When was DR. TOM BOGAERT founded?
- DR. was founded on 13-02-2015.
- Is DR. TOM BOGAERT still active?
- Yes, DR. is an active enterprise in the KBO register.
- How many employees does DR. TOM BOGAERT have?
- DR. had an average of 1 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
- What is the turnover of DR. TOM BOGAERT?
- The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €268,099 and 30 comparable companies (NACE 86220). It probably lies between €360,000 and €560,000.
- Is DR. TOM BOGAERT profitable?
- In financial year 2025, DR. made a profit of €197,485.
- Where can I find the annual accounts of DR. TOM BOGAERT?
- DR. filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. TOM BOGAERT due?
- DR. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.